NFKB1 and psoriasis: Enrichment analysis of GO-BP and KEGG on the core targets further suggests that Qubi Formula could intervene in psoriasis through multiple biological processes by acting on several signaling pathways, involving VEGF, JAK-STAT, TLRs, NF-κB, and lymphocyte differentiation-related pathways.